Avastin is No Wonder Drug: Report

by Rajashri on  July 7, 2008 at 2:20 PM Drug News   - G J E 4
 Avastin is No Wonder Drug: Report
A report in The New York Times has revealed that cancer drug Avastin may not be the wonder drug it was previously believed to be. Currently Avastin, or bevacizumab, is approved by the U.S. Food and Drug Administration for treating advanced lung and breast cancer.

Dr. Leonard Saltz, a colon cancer specialist at Memorial Sloan-Kettering Cancer Center in New York told the NYT that the benefits of Avastin may be less than what was believed.

Avastin is costly with a year's dose racking up $100,000.

Barbara Brenner, executive director of advocacy group Breast Cancer Action feels that there is a need for public discussion before recommending Avastin for wider use.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

More News on: